Evidence map›Paper›PMID 36949885›Full record

ArticleFrontiers in bioengineering and biotechnology2023

Bacterial-mediated synthesis and characterization of copper oxide nanoparticles with antibacterial, antioxidant, and anticancer potentials.

Seyedehsaba Talebian, Bahar Shahnavaz, Masoud Nejabat, Yasaman Abolhassani, Fatemeh B Rassouli

Open access · goldFull text read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. A Composite Based onPolymers · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Eco-friendly synthesis of copper nanoparticles by usingBiochemistry and biophysics reports · 2025
    Article
  15. Sustainable, scalable nanotechnology approach using filtrate fromFrontiers in cellular and infection microbiology · 2025
    Article
  16. Antibacterial Properties of Copper Oxide Nanoparticles (Review).International journal of molecular sciences · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Seyedehsaba TalebianDepartment of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
Bahar ShahnavazDepartment of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
Masoud NejabatDepartment of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
Yasaman AbolhassaniDepartment of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, Iran.
Fatemeh B RassouliNovel Diagnostics and Therapeutics Research Group, Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran.
Ferdowsi University of Mashhad · IRMashhad University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The application of novel bacterial strains for effective biosynthesis of nanoparticles minimizes negative environmental impact and eliminates challenges of available approaches. In the present study, cell-free extract of

Indexed as

anticancer propertiesantimicrobial activityantioxidant effectscopper oxide nanoparticlesstenotrophomonas sp. BS95

Identifiers

PMID36949885
PMCPMC10025390
OpenAlexW4323316251

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read2
measurements read64
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.